Aviva
UTHR icon

Aviva’s United Therapeutics UTHR Stock Holding History

Aviva’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.8M Sell
32,903
-1,548
-4% -$872K 0.03% 442
2026
Q1 		$20.4M Buy
34,451
+1,101
+3% +$548K 0.03% 396
2025
Q4 		$16.2M Buy
33,350
+1,499
+5% +$698K 0.03% 443
2025
Q3 		$13.4M Sell
31,851
-1,271
-4% -$427K 0.02% 471
2025
Q2 		$9.52M Buy
33,122
+31,270
+1,688% +$9.35M 0.02% 527
2025
Q1 		$571K Buy
1,852
+194
+12% +$66.5K ﹤0.01% 759
2024
Q4 		$585K Sell
1,658
-6,623
-80% -$2.43M ﹤0.01% 726
2024
Q3 		$2.97M Sell
8,281
-206
-2% -$69.6K 0.01% 519
2024
Q2 		$2.7M Buy
8,487
+5,843
+221% +$1.55M 0.01% 556
2024
Q1 		$607K Buy
2,644
+63
+2% +$14.2K ﹤0.01% 840
2023
Q4 		$568K Sell
2,581
-18,044
-87% -$4.16M ﹤0.01% 861
2023
Q3 		$4.66M Buy
+20,625
New +$4.75M 0.02% 519
2023
Q2 		– Sell
-91,015
Closed -$20.4M – 1023
2023
Q1 		$20.4M Buy
91,015
+79,312
+678% +$19.6M 0.09% 331
2022
Q4 		$3.25M Sell
11,703
-3,191
-21% -$806K 0.02% 641
2022
Q3 		$3.12M Sell
14,894
-2,131
-13% -$476K 0.02% 640
2022
Q2 		$4.01M Buy
+17,025
New +$3.46M 0.02% 627
2021
Q2 		– Sell
-7,249
Closed -$1.21M – 978
2021
Q1 		$1.21M Sell
7,249
-5,064
-41% -$844K 0.01% 830
2020
Q4 		$1.87M Sell
12,313
-9,981
-45% -$1.31M 0.01% 685
2020
Q3 		$2.25M Buy
22,294
+3,254
+17% +$357K 0.01% 724
2020
Q2 		$2.3M Buy
+19,040
New +$2.14M 0.01% 686

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Aviva's UTHR Position: Q2 2026 in Review

Aviva reduced its United Therapeutics (UTHR) stake by 4.5% in Q2 2026, selling an estimated $872K and leaving 32,903 shares worth $17.8M. The position accounts for 0.03% of the portfolio, ranked #442.

Aviva first reported a position in UTHR in Q2 2020 and has held it in 20 quarters since. The position peaked at $20.4M in Q1 2026. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Aviva held 32,903 shares of United Therapeutics worth $17.8M as of Q2 2026.
  • Aviva sold 1,548 United Therapeutics shares in Q2 2026, an estimated $872K.
  • United Therapeutics made up 0.03% of Aviva's portfolio in Q2 2026, its #442 holding.
  • Aviva first reported a position in United Therapeutics in Q2 2020 and has held it in 20 quarters since.
  • Aviva's United Therapeutics position peaked at $20.4M in Q1 2026.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.